Cellebrite DI (CLBT) reported Q3 non-GAAP earnings late Wednesday of $0.14 per diluted share, unchanged from a year earlier.

Analysts polled by FactSet expected $0.13.

Revenue in the three months ended Sept. 30 rose to $126 million from $106.9 million a year earlier.

Analysts surveyed by FactSet projected $123 million.

The company expects Q4 revenue of $123 million to $128 million. Analysts polled by FactSet project $125.6 million.

The company expects full-year revenue in the range of $470 million to $475 million, compared with its prior forecast of $465 million to $475 million. Analysts surveyed by FactSet project $469.4 million.

Cellebrite DI shares jumped 14% in after-hours trading.